These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Current understanding of malignant hyperthermia: genesis, prevention, and treatment. Katz DN CRNA; 1992 May; 3(2):54-63. PubMed ID: 1483145 [TBL] [Abstract][Full Text] [Related]
6. [Fulminant malignant hyperthermia during the 6th general anesthesia using volatile anesthetics]. Striebel HW; Lechner J; Wiegand C; Hartung E Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):475-80. PubMed ID: 1786310 [TBL] [Abstract][Full Text] [Related]
7. Dantrolene plasma and urine concentrations after oral pretreatment for malignant hyperthermia: report of a case. Wuis EW; Driessen JJ; Evers J; Vree TB; van der Kleyn E Eur J Anaesthesiol; 1986 May; 3(3):219-23. PubMed ID: 3780690 [TBL] [Abstract][Full Text] [Related]
8. Malignant hyperthermia: current perspectives. Felice-Johnson J; Sudds T; Bennett G Am J Hosp Pharm; 1981 May; 38(5):646-51. PubMed ID: 7282692 [TBL] [Abstract][Full Text] [Related]
9. Dantrolene sodium in the treatment of malignant hyperthermia. A case report. Harrison GG S Afr Med J; 1981 Dec; 60(23):909-10. PubMed ID: 7302773 [TBL] [Abstract][Full Text] [Related]
10. [A case of malignant hyperthermia; successful treatment with intravenous dantrolene sodium]. Noda B; Higa K; Naitoh H; Dan K Masui; 1985 Jun; 34(6):822-7. PubMed ID: 4032707 [No Abstract] [Full Text] [Related]
11. [A case of malignant hyperthermia without hyperthermia]. Muiños PA; Ortells MA; Sánchez G; Carrasco MS Rev Esp Anestesiol Reanim; 1995 Dec; 42(10):436. PubMed ID: 8789530 [No Abstract] [Full Text] [Related]
12. Recognizing and treating malignant hyperthermia. Corvetto MA; Taekman JM Simul Healthc; 2010 Jun; 5(3):169-72. PubMed ID: 20651479 [No Abstract] [Full Text] [Related]
13. Suspected malignant hyperthermia in a 13-month-old: today's "typical" episode--a case report. Smith CA; Carvill KA; Eckert T AANA J; 1997 Jun; 65(3):247-9. PubMed ID: 9233094 [TBL] [Abstract][Full Text] [Related]
14. [Prophylaxis with dantrolene sodium in 2 patients with susceptibility to malignant hyperthermia]. Navas E; Sánchez-Peña J; Gutiérrez-Crespo A Rev Esp Anestesiol Reanim; 1992; 39(5):309-11. PubMed ID: 1410753 [TBL] [Abstract][Full Text] [Related]
15. [Masseter muscle rigidity after suxamethonium during induction and postoperative abortive malignant hyperthermia in a patient with esophageal achalasia]. Arakawa Y; Kuroiwa M; Anzai T; Kanai A; Okamoto H; Hoka S Masui; 2004 Mar; 53(3):287-90. PubMed ID: 15071881 [TBL] [Abstract][Full Text] [Related]
16. Dantrolene sodium and management of malignant hyperthermia. Fuerst DL; Toth AJ AANA J; 1983 Aug; 51(4):406-10. PubMed ID: 6556878 [No Abstract] [Full Text] [Related]